ISES Educational Workshop - 2007


"CAS versus CEA: Evolving Indications and Emerging results - State of the Art 2007"
 

In support of its continued commitment to the continuing education of its members and interested physicians and allied health professionals, ISES organizes or sponsors several educational events throughout the year. To this end, the ISES Annual Education Workshop completed its fifth year of resounding success.

Audio downloads of this workshop will be available during October 2007 through the new collaborative partnership with CVMD.org on a complimentary basis!  Watch your email and this web site for more information or contact the ISES Office!

On Sunday, February 11, 2007 for the fifth in this well-attended series, as Dr. Frank Criado and a panel of special speakers hosted this special workshop entitled,  CAS versus CEA: Evolving Indications and Emerging Results - State of the Art 2007.

Purpose

The purpose of this workshop was to provide the latest information and data about carotid stenting versus carotid endarterectomy.

Objectives

The educational objectives of the workshop was to:

  • create awareness on the current status of carotid stenting and where it stands in relationship to surgical CEA

  • review latest CAS trial results and what they mean

  • gain insight on the future of CAS and its place in the management of carotid artery disease at present

  • learn the reimbursement status of CAS, today and tomorrow

Target Audience
Participants were vascular surgeons, interventional cardiologists and radiologists and all vascular and endovascular specialists.

Location and time

The Phoenician Resort - Pavilion Building - Scottsdale, Arizona  USA
Sunday, February 11, 2007 - 1:30 to 4:20 pm

Workshop Agenda

1:30 PM
Registration

1:30 - 2:15 PM
Exhibit Displays

2:15 - 2:25 PM
Welcome and Introduction

CAS challenges: Temporary setback for stenting . . .
or has CEA won?
Frank Criado, MD, Program Director

2:25 - 2:50 PM
Results of the EVA-3S and SPACE trials in perspective: What are the implications and where do we go from here?
Subbi Myla, MD

2:50 - 3:15 PM
Problems with CAS: Why would carotid stenting be ‘inferior’ to CEA? Will it ever become fully competitive with surgery, and how
Mark Wholey, MD

3:15 - 3:40
A current perspective for surgeons: Do we still need to ‘worry’ about CAS and other interventional developments?
Frank Criado, MD

3:40 - 4:10 PM
Panel Discussion: “Reimbursement, Technology, The Future
Myla, Wholey, Criado

4:05 - 4:20 PM
Audience Participation, Q&A

Adjournment
 

Faculty

Frank J. Criado, MD, Program Director
Subbi Myla, MD
Mark H. Wholey, MD